Host immunodeficiency is central because it reduces immune rejection, increasing the likelihood that an introduced human cell population or tumor fragment will survive and establish in the mouse. This creates a workable setting for observing how the graft responds to its host environment. The resulting model supports investigation of graft compatibility and disease-related behavior.
The mouse provides an environment that can affect whether a graft survives, establishes, and responds as expected. Because mouse and human physiology differ, the host may shape disease behavior, tissue function, and therapeutic responses in ways that do not fully represent human biology. Researchers therefore interpret findings within the limitations of the model.
Once a graft survives and establishes, researchers can examine more than simple persistence. The model may show how tumor growth or metastasis develops, how infectious disease behaves, how tissue function is maintained, or how a candidate treatment changes the observed response. These outcomes connect graft compatibility with disease mechanisms and therapeutic evaluation.
A typical workflow begins by introducing human cells or tumor fragments into an immunodeficient mouse. Researchers then assess whether the graft survives, establishes, and responds to the host environment. Depending on the study goal, they observe disease-related behavior, tissue function, or responses to a candidate treatment, generating experimental evidence for later interpretation.
These models are useful when investigators need to study human disease or evaluate a potential treatment in a living experimental setting. Supported applications include examining tumor growth and metastasis, infectious disease, tissue function, graft compatibility, and therapeutic responses. The model can reveal biological mechanisms while helping compare how disease or treatment-related effects develop.
Results require careful interpretation because the mouse and human systems do not share identical physiology. A graft’s behavior, disease response, or reaction to a candidate treatment in the mouse may therefore differ from what occurs in patients. Murine xenotransplantation can provide mechanistic and therapeutic evidence, but its findings do not directly establish clinical effectiveness.